US Stock MarketDetailed Quotes

CTXRW Citius Pharmaceuticals Inc C/Wts 00/00/2022 (To Pur Com)

Watchlist
  • 0.0000
  • 0.00000.00%
Close Nov 22 09:30 ET
0Market Cap0.00P/E (TTM)

Citius Pharmaceuticals Inc C/Wts 00/00/2022 (To Pur Com) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
(Q3)Jun 30, 2021
(Q2)Mar 31, 2021
(Q1)Dec 31, 2020
(FY)Sep 30, 2020
(Q4)Sep 30, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.00%8.92M
81.25%7.59M
13.52%9.26M
32.87%23.53M
25.66%5.2M
27.63%5.98M
-5.53%4.19M
83.38%8.16M
13.54%17.71M
13.22%4.14M
Selling and administrative expenses
6.55%4.03M
56.97%4.14M
93.43%3.8M
26.90%11.29M
9.66%2.91M
84.91%3.78M
9.07%2.64M
10.20%1.97M
27.09%8.9M
61.79%2.65M
-General and administrative expense
6.55%4.03M
56.97%4.14M
93.43%3.8M
26.90%11.29M
9.66%2.91M
84.91%3.78M
9.07%2.64M
10.20%1.97M
27.09%8.9M
61.79%2.65M
Research and development costs
121.81%4.89M
122.53%3.45M
-11.84%5.46M
38.89%12.24M
54.17%2.29M
-16.66%2.2M
-23.05%1.55M
132.35%6.19M
2.51%8.81M
-26.25%1.49M
Operating profit
-49.00%-8.92M
-81.25%-7.59M
-13.52%-9.26M
-32.87%-23.53M
-25.66%-5.2M
-27.63%-5.98M
5.53%-4.19M
-83.38%-8.16M
-13.54%-17.71M
-13.22%-4.14M
Net non-operating interest income expense
-47.23%53.02K
-54.78%29.57K
257.10%33.98K
379.04%250.99K
275.27%75.6K
1,045.34%100.48K
704.68%65.39K
-38.00%9.52K
44.66%52.39K
175.82%20.15K
Non-operating interest income
-48.73%53.02K
-57.35%29.57K
152.02%33.98K
284.66%261.83K
220.30%75.6K
694.38%103.41K
472.67%69.33K
-30.28%13.48K
29.26%68.07K
105.23%23.6K
Non-operating interest expense
--0
--0
--0
-30.84%10.84K
--0
-30.93%2.93K
-1.03%3.94K
-0.58%3.97K
-4.68%15.67K
-17.63%3.46K
Other net income (expense)
105.50%226.47K
166.56K
59.92K
110.21K
0
Special income (charges)
----
----
----
--166.56K
----
----
----
----
----
----
-Less:Other special charges
----
----
----
---166.56K
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
-45.63%59.92K
--0
--59.92K
----
----
--110.21K
--0
Income before tax
-52.19%-8.86M
-83.41%-7.56M
-13.24%-9.23M
-31.38%-23.05M
-20.40%-4.96M
-24.44%-5.82M
6.84%-4.12M
-88.48%-8.15M
-12.76%-17.55M
-12.90%-4.12M
Income tax
Net income
-52.19%-8.86M
-83.41%-7.56M
-13.24%-9.23M
-31.38%-23.05M
-20.40%-4.96M
-24.44%-5.82M
6.84%-4.12M
-88.48%-8.15M
-12.76%-17.55M
-12.90%-4.12M
Net income continuous Operations
-52.19%-8.86M
-83.41%-7.56M
-13.24%-9.23M
-31.38%-23.05M
-20.40%-4.96M
-24.44%-5.82M
6.84%-4.12M
-88.48%-8.15M
-12.76%-17.55M
-12.90%-4.12M
Minority interest income
Net income attributable to the parent company
-52.19%-8.86M
-83.41%-7.56M
-13.24%-9.23M
-31.38%-23.05M
-20.40%-4.96M
-24.44%-5.82M
6.84%-4.12M
-88.48%-8.15M
-12.76%-17.55M
-12.90%-4.12M
Preferred stock dividends
Other preferred stock dividends
0
1.45M
0
1.45M
0
0
Net income attributable to common stockholders
-21.84%-8.86M
-83.41%-7.56M
-13.24%-9.23M
-39.65%-24.51M
-20.40%-4.96M
-55.44%-7.27M
6.84%-4.12M
-88.48%-8.15M
-12.76%-17.55M
-12.90%-4.12M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021(Q3)Jun 30, 2021(Q2)Mar 31, 2021(Q1)Dec 31, 2020(FY)Sep 30, 2020(Q4)Sep 30, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 49.00%8.92M81.25%7.59M13.52%9.26M32.87%23.53M25.66%5.2M27.63%5.98M-5.53%4.19M83.38%8.16M13.54%17.71M13.22%4.14M
Selling and administrative expenses 6.55%4.03M56.97%4.14M93.43%3.8M26.90%11.29M9.66%2.91M84.91%3.78M9.07%2.64M10.20%1.97M27.09%8.9M61.79%2.65M
-General and administrative expense 6.55%4.03M56.97%4.14M93.43%3.8M26.90%11.29M9.66%2.91M84.91%3.78M9.07%2.64M10.20%1.97M27.09%8.9M61.79%2.65M
Research and development costs 121.81%4.89M122.53%3.45M-11.84%5.46M38.89%12.24M54.17%2.29M-16.66%2.2M-23.05%1.55M132.35%6.19M2.51%8.81M-26.25%1.49M
Operating profit -49.00%-8.92M-81.25%-7.59M-13.52%-9.26M-32.87%-23.53M-25.66%-5.2M-27.63%-5.98M5.53%-4.19M-83.38%-8.16M-13.54%-17.71M-13.22%-4.14M
Net non-operating interest income expense -47.23%53.02K-54.78%29.57K257.10%33.98K379.04%250.99K275.27%75.6K1,045.34%100.48K704.68%65.39K-38.00%9.52K44.66%52.39K175.82%20.15K
Non-operating interest income -48.73%53.02K-57.35%29.57K152.02%33.98K284.66%261.83K220.30%75.6K694.38%103.41K472.67%69.33K-30.28%13.48K29.26%68.07K105.23%23.6K
Non-operating interest expense --0--0--0-30.84%10.84K--0-30.93%2.93K-1.03%3.94K-0.58%3.97K-4.68%15.67K-17.63%3.46K
Other net income (expense) 105.50%226.47K166.56K59.92K110.21K0
Special income (charges) --------------166.56K------------------------
-Less:Other special charges ---------------166.56K------------------------
Other non- operating income (expenses) -------------45.63%59.92K--0--59.92K----------110.21K--0
Income before tax -52.19%-8.86M-83.41%-7.56M-13.24%-9.23M-31.38%-23.05M-20.40%-4.96M-24.44%-5.82M6.84%-4.12M-88.48%-8.15M-12.76%-17.55M-12.90%-4.12M
Income tax
Net income -52.19%-8.86M-83.41%-7.56M-13.24%-9.23M-31.38%-23.05M-20.40%-4.96M-24.44%-5.82M6.84%-4.12M-88.48%-8.15M-12.76%-17.55M-12.90%-4.12M
Net income continuous Operations -52.19%-8.86M-83.41%-7.56M-13.24%-9.23M-31.38%-23.05M-20.40%-4.96M-24.44%-5.82M6.84%-4.12M-88.48%-8.15M-12.76%-17.55M-12.90%-4.12M
Minority interest income
Net income attributable to the parent company -52.19%-8.86M-83.41%-7.56M-13.24%-9.23M-31.38%-23.05M-20.40%-4.96M-24.44%-5.82M6.84%-4.12M-88.48%-8.15M-12.76%-17.55M-12.90%-4.12M
Preferred stock dividends
Other preferred stock dividends 01.45M01.45M00
Net income attributable to common stockholders -21.84%-8.86M-83.41%-7.56M-13.24%-9.23M-39.65%-24.51M-20.40%-4.96M-55.44%-7.27M6.84%-4.12M-88.48%-8.15M-12.76%-17.55M-12.90%-4.12M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data